Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
GPx3 dysregulation impacts adipose tissue insulin receptor expression and sensitivity
Robert Hauffe, Vanessa Stein, Chantal Chudoba, Tanina Flore, Michaela Rath, Katrin Ritter, Mareike Schell, Kristina Wardelmann, Stefanie Deubel, Johannes Florian Kopp, Maria Schwarz, Kai Kappert, Matthias Blüher, Tanja Schwerdtle, Anna P. Kipp, André Kleinridders
Robert Hauffe, Vanessa Stein, Chantal Chudoba, Tanina Flore, Michaela Rath, Katrin Ritter, Mareike Schell, Kristina Wardelmann, Stefanie Deubel, Johannes Florian Kopp, Maria Schwarz, Kai Kappert, Matthias Blüher, Tanja Schwerdtle, Anna P. Kipp, André Kleinridders
View: Text | PDF
Research Article Endocrinology Metabolism

GPx3 dysregulation impacts adipose tissue insulin receptor expression and sensitivity

  • Text
  • PDF
Abstract

Insulin receptor signaling is crucial for white adipose tissue (WAT) function. Consequently, lack of insulin receptor (IR) in WAT results in a diabetes-like phenotype. Yet, causes for IR downregulation in WAT of patients with diabetes are not well understood. By using multiple mouse models of obesity and insulin resistance, we identify a common downregulation of IR with a reduction of mRNA expression of selenoproteins Txnrd3, Sephs2, and Gpx3 in gonadal adipose tissue. Consistently, GPX3 is also decreased in adipose tissue of insulin-resistant and obese patients. Inducing Gpx3 expression via selenite treatment enhances IR expression via activation of the transcription factor Sp1 in 3T3-L1 preadipocytes and improves adipocyte differentiation and function. Feeding mice a selenium-enriched high-fat diet alleviates diet-induced insulin resistance with increased insulin sensitivity, decreased tissue inflammation, and elevated IR expression in WAT. Again, IR expression correlated positively with Gpx3 expression, a phenotype that is also conserved in humans. Consequently, decreasing GPx3 using siRNA technique reduced IR expression and insulin sensitivity in 3T3-L1 preadipocytes. Overall, our data identify GPx3 as a potentially novel regulator of IR expression and insulin sensitivity in adipose tissue.

Authors

Robert Hauffe, Vanessa Stein, Chantal Chudoba, Tanina Flore, Michaela Rath, Katrin Ritter, Mareike Schell, Kristina Wardelmann, Stefanie Deubel, Johannes Florian Kopp, Maria Schwarz, Kai Kappert, Matthias Blüher, Tanja Schwerdtle, Anna P. Kipp, André Kleinridders

×

Figure 7

Gpx3 dysregulation causes insulin receptor downregulation and insulin resistance.

Options: View larger image (or click on image) Download as PowerPoint

Gpx3 dysregulation causes insulin receptor downregulation and insulin r...
(A) mRNA expression of the epigonadal selenoprotein transcriptome of mice after 12 weeks of either HFD or SRHFD (n = 12). (B) Mean Gpx3/Ir ratios in gWAT of (upper) healthy and HIRO mice (n = 12) and WAT of (lower) normal-weight (BMI < 25, n = 28) and overweight/obese (BMI > 25, n = 274) human patients. (C) Correlation between Ir and Gpx3 expression in gWAT of healthy and HIRO mice (n = 6–12). (D and E) Correlation between Sephs2 (D) or Txnrd3 (E) with Ir expression in gWAT of healthy and HIRO mice (n = 6–12). (F) Correlation between IR and GPX3 in human subcutaneous WAT (scWAT) (n = 302). (G) Correlation between HOMA-IR and GPX3 expression in human scWAT (n = 215). (H) Expression of Gpx3 and Ir after siRNA-mediated knockdown of GPx3 (NT, nontarget) in 3T3-L1 preadipocytes after selenite treatment. n = 7 (Gpx3)/12 (Ir). (I) Western blot of 3T3-L1 preadipocytes after siRNA mediated knockdown of GPx3 (densitometry from biological replicate experiments, n = 3). (J) Western blot of insulin-stimulated 3T3-L1 preadipocytes after siRNA-mediated knockdown of GPx3 (densitometry from biological replicate experiments, n = 3). Correlation calculated using Pearson’s correlation coefficients; linear regression analysis was used for best-fit curve showing 95% CI in dashed lines. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 after 2-tailed Student’s t test. All data are presented as mean ± SEM.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts